Redhill Biopharma
RDHL
11 hedge funds and large institutions have $48.8K invested in Redhill Biopharma in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 9 closing their positions.
0.03% more ownership
Funds ownership: 0% → 0.03% (+0.03%)
31% less funds holding
Funds holding: 16 → 11 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
93% less capital invested
Capital invested by funds: $720K → $48.8K (-$671K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$3.9K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$2.19K |
| 3 |
Morgan Stanley
New York
|
+$1.63K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$69 |
| 5 |
CPA
Capital Performance Advisors
Walnut Creek,
California
|
+$49 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$497K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$56K |
| 3 |
GS
Gagnon Securities
New York
|
-$43K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$40.2K |
| 5 |
Jane Street
New York
|
-$17.3K |
RDHL Hedge Fund Activity: Q3 2024 in Review
11 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2024, worth a combined $48.8K — down 93% from $720K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of RDHL and 4 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $3.9K. The largest seller was Sabby Management, exiting entirely with an estimated $497K sold.
- 11 institutional investors held Redhill Biopharma (RDHL) as of Q3 2024, down from 16 in Q2 2024.
- Funds reported $48.8K of Redhill Biopharma stock for Q3 2024, down 93% quarter-over-quarter.
- 4 funds opened new Redhill Biopharma positions in Q3 2024 and 9 closed out, a net change of -5 holders.
- The largest Redhill Biopharma buyer in Q3 2024 was Osaic Holdings, an estimated $3.9K added.
- The largest Redhill Biopharma seller in Q3 2024 was Sabby Management, an estimated $497K sold.
Based on aggregated 13F filings for Q3 2024.